Gen-Probe Aptima Combo 2 Assay
Dna-Reagents, Neisseria. 510(k) K043224, from Gen-Probe, Inc. (San Diego, CA). Product code LSL, class 2.
As of Nov 21, 2026, K043224 is an FDA 510(k) held by Gen-Probe, Inc., substantially equivalent on Aug 9, 2005 after 260 days, with no recalls tied to it in FDA's recall database.
- Review time: 260 days
- Recalls: 0
- Cited as a predicate by: 4 devices
AC2 Assay package insert: The APTIMA Combo 2 Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) in clinician-collected endocervical, vaginal, and male urethral swab specimens, patient-collected vaginal swab…
- Gen-Probe Aptima Combo 2 AssayK003395 · Gen-Probe, Inc. · May 21, 2001
- Thinprep(R) Processor, Model TP 2000P950039 · Hologic, Inc. · May 20, 1996
- Xpert Ct/NgK121710 · Cepheid · Dec 27, 2012
- Abbott M2000SP and Abbott M2000RT, Models 9K14-01 (G-Series), 9K14-02 (E-Series), 9K1501K092705 · Abbott Molecular, Inc. · May 28, 2010
- Abbott Realtime Ct/Ng and Abbott Multi-Collect Specimen Collection Kit, Models 8L07-91, 9K12-03K092704 · Abbott Molecular, Inc. · May 28, 2010
- Abbott Realtime Ct/Ng Assay and Multi-Collect Specimen Collection KitK080739 · Abbott Molecular, Inc. · Jul 10, 2008
- Aptima Neisseria gonorrhoeae AssayK231329 · Hologic, Inc. · Jan 26, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 22, 2004
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3390
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files